OR WAIT null SECS
© 2023 MJH Life Sciences and Practical Cardiology. All rights reserved.
© 2023 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
Contributing Editor Christine Blank is a freelance writer based in Florida.
October 07, 2015
After much criticism on the price of 2 new cholesterol-lowering drugs, Praluent and Repatha, Express Scripts said this week it will now include both drugs in its National Preferred Formulary.